BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.
7 auth. Pierrick G. J. Fournier, Sandrine Boissier, S. Filleur, J. Guglielmi, F. Cabon, M. Colombel, ... P. Clézardin
9 2002
9
🐜
🦁 SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.
8 auth. S. Filleur, A. Courtin, S. Ait-Si-Ali, J. Guglielmi, C. Merle, A. Harel-Bellan, ... P. Clézardin, F. Cabon
8 2003
8
🦁
🐜 Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche
15 auth. M. Plebanek, N. Angeloni, E. Vinokour, Jia Li, Anna Henkin, Dalia Martinez-Marin, S. Filleur, Reshma Bhowmick, J. Henkin, S. Miller, ... I. Ifergan, Yesung Lee, I. Osman, C. Thaxton, O. Volpert
7 2017
7
🐜
🦁 Characterization of PEDF: A multi‐functional serpin family protein
S. Filleur, T. Nelius, W. D. Riese, R. Kennedy
7 2009
7
🦁
🦁 Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer.
12 auth. S. Filleur, K. Volz, T. Nelius, Y. Mirochnik, Hanhua Huang, T. Zaichuk, ... M. Aymerich, S. Becerra, R. Yap, D. Veliceasa, Emelyn H. Shroff, O. Volpert
7 2005
7
🦁
🐜 CBP/p300 histone acetyl-transferase activity is important for the G1/S transition
10 auth. S. Ait-Si-Ali, A. Polesskaya, S. Filleur, R. Ferreira, A. Duquet, P. Robin, ... Arlette Vervish, D. Trouche, F. Cabon, A. Harel-Bellan
7 2000
7
🐜
🐬 Nuclear Factor of Activated T Cells Balances Angiogenesis Activation and Inhibition
T. Zaichuk, Emelyn H. Shroff, Rebekah Emmanuel, S. Filleur, T. Nelius, O. Volpert
7 2004
7
🐬
🦁 In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects.
8 auth. S. Filleur, O. Volpert, A. Degeorges, C. Voland, F. Reiher, P. Clézardin, ... N. Bouck, F. Cabon
6 2001
6
🦁
🐜 AFM nano-mechanics and calcium dynamics of prostate cancer cells with distinct metastatic potential.
9 auth. Lyndon D. Bastatas, Dalia Martinez-Marin, J. Matthews, Jood Hashem, Y. J. Lee, S. Sennoune, ... S. Filleur, R. Martínez‐Zaguilán, Soyeun Park
6 2012
6
🐜
🐢 Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy
T. Nelius, T. Klatte, W. Riese, A. Haynes, S. Filleur
6 2010
6
🐢
🐜 Human breast tumors override the antiangiogenic effect of stromal thrombospondin‐1 in vivo
8 auth. A. Fontana, S. Filleur, J. Guglielmi, L. Frappart, G. Bruno‐Bossio, Sandrine Boissier, ... F. Cabon, P. Clézardin
6 2005
6
🐜